Trial Outcomes & Findings for Pain Program for Active Coping & Training (NCT NCT02113592)

NCT ID: NCT02113592

Last Updated: 2023-08-28

Results Overview

Reliable and valid tool that measures patients' pain intensity and functional interference. The primary outcome of pain impact is assessed with the 4-item PEGS scale, a composite of pain intensity, and interference with enjoyment of life, general activity, and sleep (range, 0-10, higher score = worse pain impact).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

850 participants

Primary outcome timeframe

Collected every 3 months for 1 year

Results posted on

2023-08-28

Participant Flow

Unit of analysis: Primary care provider cluster

Participant milestones

Participant milestones
Measure
Cognitive Behavioral Therapy (CBT) Intervention
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Overall Study
STARTED
433 53
417 53
Overall Study
COMPLETED
414 53
402 53
Overall Study
NOT COMPLETED
19 0
15 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Pain Program for Active Coping & Training

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=433 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=417 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Total
n=850 Participants
Total of all reporting groups
Age, Continuous
61.4 years
STANDARD_DEVIATION 11.9 • n=5 Participants
59.2 years
STANDARD_DEVIATION 12.4 • n=7 Participants
60.3 years
STANDARD_DEVIATION 12.2 • n=5 Participants
Sex: Female, Male
Female
287 Participants
n=5 Participants
286 Participants
n=7 Participants
573 Participants
n=5 Participants
Sex: Female, Male
Male
146 Participants
n=5 Participants
131 Participants
n=7 Participants
277 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic ethnicity
16 Participants
n=5 Participants
12 Participants
n=7 Participants
28 Participants
n=5 Participants
Race/Ethnicity, Customized
White (race)
334 Participants
n=5 Participants
317 Participants
n=7 Participants
651 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American (race)
55 Participants
n=5 Participants
55 Participants
n=7 Participants
110 Participants
n=5 Participants
Race/Ethnicity, Customized
Other (race)
44 Participants
n=5 Participants
45 Participants
n=7 Participants
89 Participants
n=5 Participants
Region of Enrollment
United States
433 participants
n=5 Participants
417 participants
n=7 Participants
850 participants
n=5 Participants
Average daily dose of opioids
28.5 Morphine Milligram Equivalents (MME)
n=5 Participants
30.8 Morphine Milligram Equivalents (MME)
n=7 Participants
29.6 Morphine Milligram Equivalents (MME)
n=5 Participants

PRIMARY outcome

Timeframe: Collected every 3 months for 1 year

Reliable and valid tool that measures patients' pain intensity and functional interference. The primary outcome of pain impact is assessed with the 4-item PEGS scale, a composite of pain intensity, and interference with enjoyment of life, general activity, and sleep (range, 0-10, higher score = worse pain impact).

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=414 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS")
3-Month Follow-Up
5.486 score on a scale
Interval 5.272 to 5.699
6.210 score on a scale
Interval 5.994 to 6.426
Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS")
6-Month Follow-Up
5.516 score on a scale
Interval 5.316 to 5.715
6.197 score on a scale
Interval 5.994 to 6.399
Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS")
Baseline
6.485 score on a scale
Interval 6.29 to 6.681
6.645 score on a scale
Interval 6.447 to 6.843
Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS")
9-Month Follow-up
5.546 score on a scale
Interval 5.342 to 5.75
6.183 score on a scale
Interval 5.976 to 6.39
Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS")
12-Month Follow-Up
5.576 score on a scale
Interval 5.349 to 5.803
6.170 score on a scale
Interval 5.94 to 6.4

SECONDARY outcome

Timeframe: Collected every 3 months for 1 year

Pain-related disability will be assessed using the 24-item Roland Morris Disability Questionnaire (range, 0-1, higher score = worse function)

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=414 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Pain-related Disability
Baseline
0.672 score on a scale
Interval 0.652 to 0.691
0.692 score on a scale
Interval 0.672 to 0.711
Pain-related Disability
3-Month Follow-Up
0.612 score on a scale
Interval 0.591 to 0.633
0.675 score on a scale
Interval 0.654 to 0.696
Pain-related Disability
6-Month Follow-Up
0.609 score on a scale
Interval 0.59 to 0.629
0.678 score on a scale
Interval 0.658 to 0.698
Pain-related Disability
9-Month Follow-Up
0.607 score on a scale
Interval 0.586 to 0.627
0.681 score on a scale
Interval 0.66 to 0.701
Pain-related Disability
12-Month Follow-Up
0.604 score on a scale
Interval 0.581 to 0.626
0.683 score on a scale
Interval 0.661 to 0.706

SECONDARY outcome

Timeframe: Collected every 3 months for 1 year

Average daily dose of opioids per 3-month quarter measured in morphine milligram equivalents (MME)

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=414 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Average Daily Dose of Opioids
9-Month Follow-Up
44.571 MME/day
Interval 37.396 to 51.745
54.430 MME/day
Interval 47.142 to 61.719
Average Daily Dose of Opioids
12-Month Follow-Up
43.536 MME/day
Interval 36.085 to 50.986
53.298 MME/day
Interval 45.725 to 60.871
Average Daily Dose of Opioids
Baseline
47.458 MME/day
Interval 40.647 to 54.269
55.252 MME/day
Interval 48.333 to 62.171
Average Daily Dose of Opioids
3-Month Follow-Up
46.641 MME/day
Interval 39.61 to 53.627
56.695 MME/day
Interval 49.556 to 63.834
Average Daily Dose of Opioids
6-Month Follow-Up
45.606 MME/day
Interval 38.574 to 52.638
55.563 MME/day
Interval 48.421 to 62.704

SECONDARY outcome

Timeframe: Collected at baseline and 6 months (post-treatment)

Patient satisfaction with health care services will be assessed using two distinct items: * \[Satisfaction with primary care services\]: In the past 3 months, how satisfied have you been with your primary care services? (1, Very dissatisfied; 2, Mildly dissatisfied; 3, Indifferent; 4, Mostly satisfied; 5, Very satisfied) * \[Satisfaction with pain services\]: In the past 3 months, how satisfied have you been with the pain services you have received? (1, Very dissatisfied; 2, Mildly dissatisfied; 3, Indifferent; 4, Mostly satisfied; 5, Very satisfied) Each item is scored individually; (range=1-5, higher score = greater satisfaction)

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=414 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Patient Satisfaction
Satisfaction with primary care services (Baseline)
4.263 score on a scale
Interval 4.162 to 4.365
4.237 score on a scale
Interval 4.134 to 4.339
Patient Satisfaction
Satisfaction with primary care services (Post-Treatment)
4.240 score on a scale
Interval 4.115 to 4.365
3.984 score on a scale
Interval 3.856 to 4.112
Patient Satisfaction
Satisfaction with pain services (Baseline)
3.658 score on a scale
Interval 3.54 to 3.776
3.581 score on a scale
Interval 3.461 to 3.7
Patient Satisfaction
Satisfaction with pain services (Post-Treatment)
4.080 score on a scale
Interval 3.954 to 4.205
3.667 score on a scale
Interval 3.538 to 3.796

SECONDARY outcome

Timeframe: Collected for 1 year post-randomization

Costs were measured based on patient utilization of health care services and all prescription/medication costs. The costs of health care encounters during the 1-year follow-up were estimated using the standardized relative resource cost algorithm (SRRCA). Pain-related health care costs were based on the pain-related health care encounters identified using diagnostic and procedure coding.

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=412 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Health Care Costs
Total Health Care Costs
21,372 Dollars
25,648 Dollars
Health Care Costs
Total Pain-Related Health Care Costs
9,395 Dollars
11,343 Dollars

SECONDARY outcome

Timeframe: Collected for 1 year post-randomization

Total Ambulatory Encounters includes encounters in the following health care service categories: Primary care; Physical therapy; Pain clinic; Other specialty medical care; Mental health; Complementary and alternative medicine; ED, urgent care, and observation beds; Hospital ambulatory visits; Same day surgeries; and Home health. Total Pain-Related Ambulatory Encounters are a subset of Total Ambulatory Encounters and were identified using CPT, HCPCS, and ICD-9-PCS or ICD-10-PCS codes

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=412 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Count of Health Care Encounters by Type (Health Care Utilization)
Total Ambulatory Encounters
20.85 Health care encounters
Interval 19.4 to 22.41
21.59 Health care encounters
Interval 20.07 to 23.22
Count of Health Care Encounters by Type (Health Care Utilization)
Total Pain-Related Ambulatory Encounters
10.42 Health care encounters
Interval 9.62 to 11.28
10.11 Health care encounters
Interval 9.33 to 10.96
Count of Health Care Encounters by Type (Health Care Utilization)
Telephone or Email Encounters
24.04 Health care encounters
Interval 22.57 to 25.6
23.18 Health care encounters
Interval 21.75 to 24.71
Count of Health Care Encounters by Type (Health Care Utilization)
Inpatient Hospital Encounters
0.22 Health care encounters
Interval 0.17 to 0.28
0.28 Health care encounters
Interval 0.22 to 0.36

SECONDARY outcome

Timeframe: Collected for 1 year post-randomization

Inpatient hospital days is the average number of days that patients stayed in hospital (total number of days spent by inpatients during the 1 year post-randomization divided by the total number of inpatient admissions)

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=412 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Inpatient Hospital Days (Health Care Utilization)
0.86 Days
Interval 0.59 to 1.26
0.22 Days
Interval 0.13 to 0.39

SECONDARY outcome

Timeframe: Collected for 1 year post-randomization

Total Pharmacy Dispenses is a count of the unique medication prescriptions dispensed.

Outcome measures

Outcome measures
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=412 Participants
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=402 Participants
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
Total Pharmacy Dispenses (Health Care Utilization)
50.45 Prescriptions dispensed
Interval 48.53 to 52.44
52.22 Prescriptions dispensed
Interval 50.21 to 54.3

Adverse Events

Cognitive Behavioral Therapy (CBT) Intervention

Serious events: 94 serious events
Other events: 0 other events
Deaths: 4 deaths

Usual Care

Serious events: 112 serious events
Other events: 0 other events
Deaths: 8 deaths

Serious adverse events

Serious adverse events
Measure
Cognitive Behavioral Therapy (CBT) Intervention
n=433 participants at risk
Cognitive behavioral therapy (CBT) intervention teaching pain self-management skills in 12 weekly, 90-minute groups delivered by an interdisciplinary team of a behavioral health specialist, nurse care manager, physical therapist, and pharmacist, embedded in primary care.
Usual Care
n=417 participants at risk
Patients in this arm receive care as usual and can utilize any pharmacologic and/or nonpharmacologic treatments available to them in their health care system without restriction.
General disorders
Hospitalization
21.7%
94/433 • Number of events 116 • Participants were monitored for serious adverse events during the one-year period of study participation.
The only adverse events monitored were serious adverse events, defined as hospitalizations and deaths, assessed systematically from electronic health record data. Assessments were conducted every 6 months throughout the study and reviewed by an independent monitor. For deaths, chart abstraction determined relatedness.
26.9%
112/417 • Number of events 171 • Participants were monitored for serious adverse events during the one-year period of study participation.
The only adverse events monitored were serious adverse events, defined as hospitalizations and deaths, assessed systematically from electronic health record data. Assessments were conducted every 6 months throughout the study and reviewed by an independent monitor. For deaths, chart abstraction determined relatedness.

Other adverse events

Adverse event data not reported

Additional Information

Lynn DeBar, PhD, MPH, Principal Investigator

Kaiser Permanente Washington Health Research Institute

Phone: 206-287-2900

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place